Sintx Technologies, Inc. (SINT)
USD 2.01
(-19.6%)
USD 2.01
(-19.6%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.59 Million USD | -34.52% |
| 2022 | 10.06 Million USD | 144.87% |
| 2021 | 4.11 Million USD | -11.44% |
| 2020 | 4.64 Million USD | 17.69% |
| 2019 | 3.94 Million USD | 26.6% |
| 2018 | 3.11 Million USD | -66.13% |
| 2017 | 9.19 Million USD | -22.62% |
| 2016 | 11.88 Million USD | -46.5% |
| 2015 | 22.22 Million USD | -45.37% |
| 2014 | 40.67 Million USD | -78.29% |
| 2013 | 187.38 Million USD | 3.11% |
| 2012 | 181.73 Million USD | 3.55% |
| 2011 | 175.49 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 7.63 Million USD | 15.8% |
| 2024 Q2 | 6.45 Million USD | -15.52% |
| 2023 Q3 | 4.82 Million USD | -8.76% |
| 2023 Q1 | 6.7 Million USD | -33.4% |
| 2023 Q2 | 5.28 Million USD | -21.18% |
| 2023 Q4 | 6.59 Million USD | 36.7% |
| 2023 FY | 6.59 Million USD | -34.52% |
| 2022 FY | 10.06 Million USD | 144.87% |
| 2022 Q4 | 10.06 Million USD | 95.59% |
| 2022 Q1 | 4.43 Million USD | 7.78% |
| 2022 Q3 | 5.14 Million USD | -5.45% |
| 2022 Q2 | 5.44 Million USD | 22.86% |
| 2021 Q2 | 4.93 Million USD | -2.95% |
| 2021 Q4 | 4.11 Million USD | -26.94% |
| 2021 FY | 4.11 Million USD | -11.44% |
| 2021 Q3 | 5.62 Million USD | 14.0% |
| 2021 Q1 | 5.08 Million USD | 9.56% |
| 2020 Q1 | 4.15 Million USD | 5.32% |
| 2020 FY | 4.64 Million USD | 17.69% |
| 2020 Q2 | 5.38 Million USD | 29.7% |
| 2020 Q4 | 4.64 Million USD | -8.91% |
| 2020 Q3 | 5.09 Million USD | -5.42% |
| 2019 Q4 | 3.94 Million USD | -13.68% |
| 2019 FY | 3.94 Million USD | 26.6% |
| 2019 Q3 | 4.57 Million USD | -5.52% |
| 2019 Q2 | 4.83 Million USD | 38.72% |
| 2019 Q1 | 3.48 Million USD | 11.91% |
| 2018 Q3 | 6.3 Million USD | -44.18% |
| 2018 Q4 | 3.11 Million USD | -50.59% |
| 2018 FY | 3.11 Million USD | -66.13% |
| 2018 Q1 | 8.83 Million USD | -4.0% |
| 2018 Q2 | 11.29 Million USD | 27.94% |
| 2017 Q3 | 9.12 Million USD | 6.06% |
| 2017 Q1 | 9.99 Million USD | -15.96% |
| 2017 FY | 9.19 Million USD | -22.62% |
| 2017 Q4 | 9.19 Million USD | 0.77% |
| 2017 Q2 | 8.6 Million USD | -13.85% |
| 2016 Q3 | 14.11 Million USD | -20.52% |
| 2016 Q4 | 11.88 Million USD | -15.75% |
| 2016 FY | 11.88 Million USD | -46.5% |
| 2016 Q1 | 20.14 Million USD | -9.33% |
| 2016 Q2 | 17.75 Million USD | -11.89% |
| 2015 Q4 | 22.22 Million USD | -42.89% |
| 2015 Q2 | 31.81 Million USD | -21.41% |
| 2015 Q3 | 38.91 Million USD | 22.32% |
| 2015 Q1 | 40.47 Million USD | -0.49% |
| 2015 FY | 22.22 Million USD | -45.37% |
| 2014 Q2 | 28.46 Million USD | 21.73% |
| 2014 Q3 | 30.39 Million USD | 6.76% |
| 2014 Q4 | 40.67 Million USD | 33.84% |
| 2014 FY | 40.67 Million USD | -78.29% |
| 2014 Q1 | 23.38 Million USD | -87.52% |
| 2013 Q4 | 187.38 Million USD | 580.0% |
| 2013 Q2 | 180.53 Million USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 187.38 Million USD | 3.11% |
| 2013 Q3 | 27.55 Million USD | -84.74% |
| 2012 Q4 | 181.73 Million USD | 0.0% |
| 2012 FY | 181.73 Million USD | 3.55% |
| 2011 FY | 175.49 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 87.137% |
| BrainsWay Ltd. | 15.31 Million USD | 56.948% |
| Cerus Corporation | 144.3 Million USD | 95.431% |
| Envoy Medical, Inc. | 9.4 Million USD | 29.877% |
| electroCore, Inc. | 8.94 Million USD | 26.294% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -23.418% |
| IceCure Medical Ltd | 4.24 Million USD | -55.239% |
| Inogen, Inc. | 121.38 Million USD | 94.568% |
| OrthoPediatrics Corp. | 72.56 Million USD | 90.914% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 77.712% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -107.2% |
| MaxCyte, Inc. | 36.1 Million USD | 81.74% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -256.781% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1450.269% |
| Orthofix Medical Inc. | 326.58 Million USD | 97.981% |
| PAVmed Inc | 57.13 Million USD | 88.461% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 74.108% |
| RxSight, Inc. | 22.18 Million USD | 70.286% |
| Sight Sciences, Inc. | 46.43 Million USD | 85.802% |
| SI-BONE, Inc. | 61.05 Million USD | 89.201% |
| TELA Bio, Inc. | 59.16 Million USD | 88.857% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 94.215% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 36.108% |
| Acutus Medical, Inc. | 54.83 Million USD | 87.978% |
| Talis Biomedical Corporation | 29.22 Million USD | 77.44% |
| Spectral AI, Inc. | 12.4 Million USD | 46.835% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 71.501% |
| CVRx, Inc. | 39.28 Million USD | 83.216% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 44.866% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -171.395% |
| Bioventus Inc. | 589.79 Million USD | 98.882% |
| Venus Concept Inc. | 107.1 Million USD | 93.844% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 87.238% |
| LivaNova PLC | 1.15 Billion USD | 99.428% |
| 908 Devices Inc. | 37.49 Million USD | 82.414% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.063% |
| Nemaura Medical Inc. | 26.37 Million USD | 75.005% |
| NeuroPace, Inc. | 86.99 Million USD | 92.422% |
| LENSAR, Inc. | 22.4 Million USD | 70.579% |
| Apyx Medical Corporation | 52.31 Million USD | 87.398% |
| Cutera, Inc. | 518.12 Million USD | 98.728% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 77.52% |
| BioSig Technologies, Inc. | 4.68 Million USD | -40.726% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 88.704% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 69.318% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.7% |
| Axonics, Inc. | 82.35 Million USD | 91.995% |
| Outset Medical, Inc. | 190.91 Million USD | 96.547% |
| IRIDEX Corporation | 24.91 Million USD | 73.537% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 94.682% |
| IRadimed Corporation | 20.73 Million USD | 68.205% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -293.847% |
| INVO Bioscience, Inc. | 19.99 Million USD | 67.027% |
| Telesis Bio, Inc. | 40.87 Million USD | 83.87% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 83.837% |
| Varex Imaging Corporation | 668.6 Million USD | 99.014% |
| Quipt Home Medical Corp. | 136.29 Million USD | 95.163% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -84.574% |
| Pulmonx Corporation | 60.63 Million USD | 89.127% |
| Dynatronics Corporation | 11.78 Million USD | 44.033% |
| Modular Medical, Inc. | 2.27 Million USD | -190.185% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -62.229% |
| Semler Scientific, Inc. | 6.27 Million USD | -5.152% |
| InMode Ltd. | 75.91 Million USD | 91.315% |
| Bruker Corporation | 2.83 Billion USD | 99.768% |
| Cytosorbents Corporation | 29.98 Million USD | 78.013% |
| DexCom, Inc. | 4.19 Billion USD | 99.843% |
| Align Technology, Inc. | 2.45 Billion USD | 99.731% |
| Viveve Medical, Inc. | 10.84 Million USD | 39.218% |
| ZimVie Inc. | 795.85 Million USD | 99.172% |
| Movano Inc. | 5.97 Million USD | -10.399% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 93.697% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1450.269% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 44.866% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 98.968% |
| Profound Medical Corp. | 12.66 Million USD | 47.947% |
| Insulet Corporation | 1.85 Billion USD | 99.645% |
| enVVeno Medical Corporation | 2.43 Million USD | -170.76% |
| Surmodics, Inc. | 65.82 Million USD | 89.984% |
| iCAD, Inc. | 8 Million USD | 17.598% |
| Nuwellis, Inc. | 6.78 Million USD | 2.758% |
| Biotricity, Inc. | 35.91 Million USD | 81.645% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 97.044% |
| Aethlon Medical, Inc. | 2.47 Million USD | -165.884% |
| InspireMD, Inc. | 8.14 Million USD | 19.025% |
| PAVmed Inc. | 57.13 Million USD | 88.461% |
| BIOLASE, Inc. | 35.34 Million USD | 81.348% |
| Beyond Air, Inc. | 29.77 Million USD | 77.857% |
| FONAR Corporation | 57.45 Million USD | 88.525% |
| AxoGen, Inc. | 101.16 Million USD | 93.483% |
| Vivani Medical, Inc. | 25.03 Million USD | 73.666% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 92.491% |
| Inari Medical, Inc. | 209.32 Million USD | 96.85% |
| UFP Technologies, Inc. | 118.04 Million USD | 94.415% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 48.048% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -201.627% |
| Tenon Medical, Inc. | 5.56 Million USD | -18.43% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -270.601% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 62.612% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.791% |
| NanoVibronix, Inc. | 2.68 Million USD | -145.458% |
| Quanterix Corporation | 78.08 Million USD | 91.557% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -84.574% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -34.964% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.369% |
| TransMedics Group, Inc. | 568.84 Million USD | 98.841% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 60.478% |
| NeuroMetrix, Inc. | 1.33 Million USD | -394.553% |
| Hyperfine, Inc. | 9.8 Million USD | 32.724% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 97.365% |
| Biomerica, Inc. | 2.66 Million USD | -147.578% |
| Bone Biologics Corporation | 831.4 Thousand USD | -692.998% |
| AVITA Medical, Inc. | 19.86 Million USD | 66.812% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -234.046% |
| Silk Road Medical, Inc | 114.15 Million USD | 94.225% |